?

當(dāng)前位置:對(duì)照品 > 實(shí)驗(yàn)試劑 > 生化試劑 >
XL-147, ≥98%
??【編號(hào)】:127130

??【產(chǎn)品名稱】:XL-147, ≥98%

??【規(guī)格】:5MG

??【用途】:

  XL-147, ≥98%

  Product Name: XL-147
  CAS號(hào):934526-89-3
  分子式:C25H25ClN6O4S
  分子量:541.02
  貯存: 儲(chǔ)存溫度-20°C
  可溶性: 25°C: DMSO 3 mg/mL; Water <1 mg/mL; Ethanol <1 mg/mL
  生化和生理學(xué)機(jī)理:
  Description:
  IC50 Value:39 nM (PI3Kα); 383 nM (PI3Kβ); 36 nM (PI3Kδ); 23 nM(PI3Kγ) [1]
  XL147 is a potent, orally bioavailable inhibitor of the class I PI3K family of lipid kinases with IC50 values in the nanomolar range in biochemical assays.
  in vitro: XL147 binds in an ATP-competitive and reversible manner, yet is highly selective against a panel of >130 human protein kinases. In cellular assays, XL147 antagonizes the production of the second messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) resulting in inhibition of phosphorylation of several downstream effectors of PI3K including Akt, ribosomal S6 kinase, and ribosomal S6 protein [1].Compared with XL147 alone, the combination exhibited a superior antitumor effect against trastuzumab-resistant tumor xenografts. Furthermore, treatment with XL147 and trastuzumab reduced the cancer stem-cell (CSC) fraction within trastuzumab-resistant cells both in vitro and in vivo [2].
  in vivo: SAR245408 induced significant differences in EFS distribution compared to control in 29 of 37 (79%) of solid tumor xenografts and in two of seven (29%) ALL. Xenografts. SAR245408 induced tumor growth inhibition meeting criteria for intermediate EFS T/C activity (EFS T/C?>?2) in 4 of 37 (11%) solid tumor xenografts [3].
  Toxicity: In vitro SAR245408 demonstrated cytotoxic activity, with a median relative IC50 value of 10.9??M (range 2.7-24.5??M) [4].
  Clinical trial: Open-label Treatment Extension Study With SAR-245408 or SAR-245409 as a Monotherapy or as a Combination Regimen. Phase 1/Phase 2
上一篇:XMD8-92, ≥99% 下一篇:YK-4-279



    ?
    首 頁 | 對(duì)照品| 標(biāo)準(zhǔn)品| 標(biāo)準(zhǔn)物質(zhì)| 實(shí)驗(yàn)試劑| 培養(yǎng)基| 菌種購(gòu)買| 新聞中心| 聯(lián)系我們| 網(wǎng)站地圖

    2011-2018 北京萊耀生物版權(quán)所有豫ICP備17046142號(hào)

    ?